Our web sites were updated.
Kaytee Bio, Co.&Ltd. and Clark Atlanta University has started the collaboration of cancer treatment using short talin inhibitors.
Japanese Organization for Medical Device Development, Inc (https://jomdd.com) has begun to launch the Talin Test as RUO in U.S.
Aug. 30th, 2018
We have begun R&D of Talin Test in Asian regions and parts of Europe.
Apr. 1st, 2017
Our patents of Talin Test have been registered in UK, France, Germany, and Italy.
Jul. 21st, 2016
We have presented our latest multi-center research about BiologicMate® for the efficacy of infliximab in 2016 EULAR Congress Meeting in London (June 8-11th, 2016). Details Here!
Mar. 25th, 2016
Kaytee Bio, Co.&Ltd. was posted on the April issue of Nature’s MedTech Dealmakers which have a journalistic feature on diagnostics.
Mar. 14th, 2016
Kaytee Bio,Co.&Ltd. concluded the License Contracts on the distribution and R&D of our technology regarding BiologicMate® and Talin Test exclusively in the countries including U.S.A. with Japanese Organization for Medical Device Development, Inc (https://jomdd.com).
Dec. 18th, 2014
We have presented our latest findings about BiologicMate® in 2014 ACR/ARHP Annual Scientific Meeting (Nov 15th-19th) in Boston.